- Open Access
Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse model
Acta Neuropathologica Communications volume 2, Article number: 49 (2014)
Small vessel disease (SVD) of the brain is a leading cause of age- and hypertension-related cognitive decline and disability. Cerebral white matter changes are a consistent manifestation of SVD on neuroimaging, progressing silently for many years before becoming clinically evident. The pathogenesis of these changes remains poorly understood, despite their importance. In particular, their pathological correlate at early stages remains largely undefined. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), caused by dominant mutations of the NOTCH3 receptor, is regarded as a paradigm for the most common form of sporadic SVD. In this study, we used immunohistochemistry, confocal microscopy and electron microscopy, together with qualitative and quantitative analyses to assess oligodendroglial, axon and myelin damage in TgPAC-Notch3R169C mice, a model of preclinical CADASIL.
The principal cerebral white matter changes in TgPAC-Notch3R169C mice are microvacuoles (≤1 μm diameter) in the myelin sheaths associated with focal myelin degradation and occurring in the absence of oligodendrocyte loss. Half the damaged myelin sheaths still contain an apparently intact axon. Clearance of myelin debris appears inefficient, as demonstrated by the significant but mild microglial reaction, with occasional myelin debris either contacted or internalized by microglial cells.
Our findings suggest that segmental intramyelinic oedema is an early, conspicuous white matter change in CADASIL. Brain white matter intramyelinic oedema is consistently found in patients and mouse models with compromised ion and water homeostasis. These data provide a starting point for novel mechanistic studies to investigate the pathogenesis of SVD-related white matter changes.
Cerebral small vessel disease (SVD) is increasingly recognized as a major health problem in developed countries, accounting for 25 to 30% of ischemic stroke  and as a leading cause of age-related cognitive decline and disability . The majority of SVD appears to result from a complex mix of genetic and cardiovascular risk factors, the most important of which are age and hypertension [3, 4].
The main manifestations of SVD on standard magnetic resonance imaging (MRI) are lacunes and white matter (WM) hyperintensities . The underlying microstructural changes responsible for WM hyperintensities are unclear, and it has been suggested that these features may simply reflect an increase in water content . Novel MRI techniques, such as diffusion tensor imaging (DTI), which measures the magnitude and direction of water diffusion, and magnetization transfer imaging (MTI), which measures the efficiency of magnetization exchange between the relatively free water protons within tissue and protons bound to macromolecules, are highly sensitive to changes in white matter tract integrity [7, 8]. Changes reflecting axonal loss and demyelination have consistently been observed in subjects with SVD. These changes are detected not only in areas of WM hyperintensities but also in white matter of normal appearance, suggesting that the WM hyperintensities observed on conventional MRI may be no more than the tip of the iceberg . WM lesions are highly prevalent in patients with SVD, and in populations at risk of SVD, including the elderly, in particular. This suggests that WM lesions probably progress silently for many years before becoming clinically evident .
Little is known about the pathophysiological events leading to WM lesions in SVD. The two prevailing hypotheses attribute WM abnormalities to chronic hypoperfusion , or to an increase in blood–brain-barrier permeability, causing fluid to leak into the surrounding brain tissue . It has also been suggested that WM changes may arise from Wallerian degeneration due to cortical neuron loss . There are several reasons for the current lack of knowledge. Firstly, SVD is highly heterogeneous and the mechanisms underlying WM lesions are potentially diverse . Secondly, the pathological correlate of WM abnormalities, particularly at early stages, remain largely undefined. WM lesions have been studied on autopsy, in patients with end-stage SVD [4, 9]. At this stage, severe white matter disorganization is the rule, with marked losses of myelin and axons, accompanied by severe vessel wall and perivascular space abnormalities .
Monogenic forms of SVD, largely indistinguishable from sporadic SVD, have been characterized in recent years . Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), caused by dominant mutations in the NOTCH3 receptor, is regarded as a paradigm for the most common form of sporadic SVD [13–15]. All NOTCH3 mutation carriers display WM abnormalities, which constitute early signs of the disease detectable well before the occurrence of stroke, cognitive impairment and disability . In the current study, we investigated a mouse model of preclinical CADASIL (TgPAC-Notch3R169C), in which cerebral WM pathology develops with aging [17, 18]. Through immunohistochemistry, confocal microscopy and electron microscopy, combined with qualitative and quantitative evaluations, we carried out, to the best of our knowledge, the first microstructural characterization of changes to brain WM in the initial stages of a pure, well defined form of SVD.
Material and methods
TgPAC-Notch3R169C (FVB/N) and TgPAC-Notch3WT (FVB/N) mice have been described elsewhere . These mice and their wild-type control littermates were bred at the animal facility on the Villemin site of Paris Diderot University (Paris, France). The TgPAC-Notch3WT mice and their non-transgenic littermates did not differ for any of the parameters assessed, and we therefore pooled the data for these two groups, which we used as a single control group. Mice were housed under a normal light/dark cycle (12 h) with standard rodent chow and tap water supplied ad libitum. All the experiments described here were conducted in full accordance with the guidelines of our local institutional animal care and use committee (Lariboisière-Villemin), and every effort was made to minimize the number of animals used.
Mice were deeply anesthetized with sodium pentobarbital (80 mg/kg) and transcardially perfused with 50 ml of 0.1 M sodium phosphate buffer (PB) followed by 200 ml of 2% glutaraldehyde/2% paraformaldehyde in PB. The skull was opened and incubated for one hour in 2% glutaraldehyde/2% paraformaldehyde in PB at 4°C, for fixation of the brain tissues. The brain was removed, cut into 1 mm-thick paramedian brain slices (median, −1 mm, +1 mm), and 1×1×1-mm blocks from the corpus callosum, internal capsule and fimbria regions were dissected under a microscope. The blocks of tissue were incubated overnight in 2% glutaraldehyde/2% paraformaldehyde in PB at 4°C and then post-fixed by incubation in 2% osmium tetroxide in PB. Then samples were dehydrated by passage through a graded series of ethanol concentrations and were then embedded in epoxy resin. Semi-thin sections were cut with an ultramicrotome (Leica EM EC7), stained with 1% toluidine blue and screened by light microscopy to select areas in which the myelin fibers were perpendicular to the cutting plane. Ultrathin sections of regions of interest were cut, mounted on copper grids, contrast stained with uranyl acetate and lead citrate and examined by transmission electron microscopy (Philips CM100).
Mice were deeply anesthetized with sodium pentobarbital (80 mg/kg) and transcardially perfused with 50 ml of PB followed by 50 ml of 4% paraformaldehyde in PB. The brain was removed, cut along the midline and postfixed by incubation overnight in 4% paraformaldehyde at 4°C. Half the brain was dehydrated, embedded in paraffin, and cut into 7 μm-thick sagittal sections on a rotary microtome (Leica RM2255). These sections were placed on silane-treated glass slides. The other half of the brain was cryoprotected by incubation in 30% sucrose solution until precipitation occurred at 4°C, transferred to a plastic cryomold filled with optimal cutting temperature compound (Tissue-tek) and immersed in a pre-chilled isopentane bath cooled with liquid nitrogen. It was then (immediately before use) cut into 16 μm-thick sagittal slices on a cryostat (Leica CM 1850), and the slices were collected in PBS in 12-well plates.
Immunodetection for myelin basic protein, Iba-1, CD68, Alzheimer precursor protein A4, phosphorylated light neurofilament, non-phosphorylated heavy neurofilament and cleaved caspase 3 was performed on free-floating cryosections. Sections were washed and blocked by incubation with 5% bovine serum albumin (BSA) in PBS supplemented with 0.4% Triton X-100 for 1 h at room temperature. They were then incubated in 0.5% BSA and 0.4% Triton X-100 at 4°C overnight, with one or two of the following primary antibodies: mouse monoclonal anti-myelin basic protein (1:2000, SMI94, Covance), rabbit polyclonal anti-degraded myelin basic protein (1:500, Millipore), rabbit polyclonal anti-Iba-1 (1:2000, Wako), rat monoclonal anti-CD68 (1:250, FA-11, AbD Serotec), rabbit monoclonal anti-phosphorylated neurofilament light (1:100, C28E10, Cell Signaling), mouse monoclonal anti-non-phosphorylated neurofilament heavy (1:50000, SMI32, Covance), mouse monoclonal anti-Alzheimer precursor protein A4 (1:1000, 22C11, Millipore), rabbit monoclonal anti-cleaved caspase 3 (1:250, Asp175/5A1E, Cell Signaling). Olig2 immunodetection was performed on paraffin-embedded sections. Samples were deparaffinized, rehydrated in graded series of ethanol concentrations and boiled in 10 mM citrate buffer (pH 6.0) for 10 minutes to unmask the antigens. The slides were allowed to cool to room temperature and were washed in PBS. Sections were blocked by incubation with 5% fetal bovine serum in PBS supplemented with 0.2% Triton X-100 for 1 h at room temperature. They were then incubated with a rabbit polyclonal anti-Olig2 antibody (1:200, Millipore) in 0.5% fetal bovine serum, overnight at 4°C.
The cryosections and paraffin-embedded sections were then incubated with AlexaFluor-conjugated secondary antibodies (1:500, Life technologies) for 2 h at room temperature. Sections were washed, counterstained with DAPI (1:10,000, Sigma-Aldrich) in PBS for 5 minutes at room temperature, mounted in a drop of Dako fluorescence mounting medium and subjected to epifluorescence imaging (Nikon eclipse 80i) or laser scanning confocal microscopy (Olympus BX61). The same imaging parameters were used for all images acquired from all the groups compared. A detailed description of all the primary and secondary antibodies used is provided in Additional file 1: (Table S1).
All quantitative image analyses were performed in blind conditions.
Lesions on electron micrographs
Lesions were first counted in the corpus callosum when the mice were 20 months old (n = 4 TgPAC-Notch3R169C mice and 4 control mice). Images were acquired randomly, with a magnification of x3,400 (6 fields per section, 1–2 sections per mouse). A 400 μm2 square was randomly drawn on each image and the lesions located within the square (excluding 2 borders) were counted manually. Results are expressed as the number of lesions per 1000 μm2. The lesions present in TgPAC-Notch3R169C mice were characterized further. A mean of 200 lesions per section (from 7–12 fields, 1–2 sections per mouse, n = 4 mice) were manually and systematically identified with NIH ImageJ software and assessed to determine the lesion type, its subcellular location, its position relative to the myelin sheath, and the presence or absence of an axon. Degenerating axons were distinguished on the basis of an accumulation of mitochondria and lysosomes in the axoplasm, vacuolar bodies, a disrupted plasma membrane, or a dark axoplasm. The other axons were considered to be “apparently intact”. In vacuolated lesions, area and equivalent diameter were measured. The results are expressed as a percentage of the total lesion count.
The g-ratio (diameter of the axon/total outer myelin sheath diameter) was determined on electron micrographs of the corpus callosum of 20-month old mice (n = 3 TgPAC-Notch3R169C mice and 3 control mice). Images were acquired randomly at a magnification x17,500. The g-ratio was calculated for at least 120 randomly selected apparently intact myelin sheaths (i.e., non-vacuolated) per genotype, with the GRatio for ImageJ plugin (Ingo Bormuth, http://gratio.efil.de/). We then plotted g-ratio against axon diameter.
The amount of myelin debris was determined at the ages of 12 months (n = 4 TgPAC-Notch3R169C mice and 4 control mice) and 20 months (n = 5 TgPAC-Notch3R169C mice and 8 control mice). Epifluorescence images were obtained for sections (1.5 ± 0.4 mm lateral to the midline) labeled with SMI94, with a 20x objective, from both the anterior (2 fields) and posterior (1 field) parts of the corpus callosum (3 fields per section, 4–10 sections per mouse), using a CCD camera and identical parameters. Myelin debris were counted with a custom-made three-step NIH ImageJ macro: manual delineation of the corpus callosum, automatic detection of the foci with the highest intensity relative to the regional background (local maxima) and automated counting of hyperintense foci and measurement of the area of the corpus callosum. The results are expressed as the number of SMI94 hyperintense foci over the area of the corpus callosum.
Presence of axons within damaged myelin fibers
We checked altered myelin sheaths for the presence of the axon in 20-month-old TgPAC-Notch3R169C mice (n = 5). Confocal images of the fimbria were generated with a x60 oil-immersion objective, from sections labeled with SMI94 (myelin debris, red) and C28E10 (axon, green) (88 × 88 μm field, 2 fields per section, 2 sections per mouse). We used a custom-made two-step NIH ImageJ macro to assess the colocalization of myelin debris with axons. Myelin debris (15–20 debris per image, 4 images per mouse, 5 mice) were first randomly selected on the red channel image (blind to the green channel) and two perpendicular lines (width: 1 pixel) were drawn over each. The pixel intensity values of the red and green channels were then plotted along each of the two lines (two profiles per myelin debris). Myelin debris with a green profile peak within the red profile curve over at least one of the two lines were classified as “axon present”, whereas myelin debris not fulfilling this criterion were classified as “axon absent”. Results are expressed as a percentage of the total number of myelin debris analyzed.
The number of Olig2-positive cells was determined at the age of 20 months (n = 4 TgPAC-Notch3R169C mice and 4 control mice). Epifluorescence images were generated from sections (1.2 ± 0.3 mm lateral to the midline) labeled with anti-Olig2 antibody, with a x20 objective, from the fimbria and the posterior part of the corpus callosum (4 sections per mouse). A custom NIH ImageJ macro was developed for the quantification of oligodendrocyte density. All steps were automated unless otherwise indicated. Briefly the global region of interest (global ROI) was delimited manually, its area was measured and the part of the image outside the global ROI was excluded. All the remaining nuclei in the DAPI channel were then binarized, separated when overlapping (watershed method) and converted into separate regions of interest (nucleus ROIs). For each nucleus ROI, mean intensity was measured for the Olig2 channel and compared with the surrounding mean intensity (mean intensity of the nucleus ROI enlarged by 70 pixels): the nucleus ROI was considered to correspond to an Olig2-positive nucleus if its mean intensity was at least 1.1 times the surrounding intensity. Oligodendrocyte density is expressed as the ratio of the total number of Olig2-positive nuclei to the area of the global ROI.
Total and reactive microglia were quantified in 20-month-old mice (n = 6 TgPAC-Notch3R169C mice and 4 control mice). Epifluorescence images were generated for sections (1.5 ± 0.4 mm lateral to the midline) labeled for Iba-1 (total microglial population) and CD68 (reactive microglia) from the corpus callosum (4–6 sections per mouse), with a 40x objective. Total and reactive microglia were quantified with a custom-built NIH ImageJ macro. The corpus callosum was delimited manually, its area was measured and the part of the image outside the corpus callosum was excluded. Immunostained microglia were then binarized by automatic thresholding (the Otsu method) and the area covered by the microglia was determined. Results are expressed as the ratio of the area covered by the microglia to that of the corpus callosum.
Clearance of myelin debris
The phagocytosis of myelin debris by microglial cells in the corpus callosum was assessed in 20 month-old TgPAC-Notch3R169C mice. Electron micrographs were acquired at a magnification of x3,400 (10–12 fields per section, 6 sections per mouse, n = 4 mice). Confocal images were generated for sections labeled with SMI94 and anti-Iba-1 antibodies, with a x20 oil-immersion objective (155 × 155 μm field, 4 fields per section, 2 sections per mouse, n = 4 mice). Myelin debris coming into contact with or internalized by microglial cell processes were counted manually on electron micrographs and on confocal images. The results are expressed as the ratio of the number of myelin debris coming into contact with or internalized by microglia to the total number of myelin debris.
Data are expressed as the mean ± standard error of the mean (SEM). Student’s t tests were used for comparisons between groups. P values <0.05 were considered significant.
TgPAC-Notch3R169C mice display intramyelinic oedema in the brain WM
We previously reported that TgPAC-Notch3R169C mice display cerebral WM pathology upon aging . We characterized this pathology further, by assessing the integrity of the cerebral WM on semithin resin sections of corpus callosum, fimbria and internal capsule from TgPAC-Notch3R169C and control mice at the age of 20 months. Toluidine blue-stained semithin sections showed widespread spongiosis confined to the myelinated fiber tracts, in all regions of TgPAC-Notch3R169C mice analyzed, but not in control mice (Figure 1A-B and Additional file 2: Figure S1, n = 4 TgPAC-Notch3R169C and 4 control mice). The adjacent gray matter and the cortex of the mutant mice were almost entirely spared (Additional file 2: Figure S1).
We undertook a qualitative and quantitative electron microscopy analysis of cerebral WM in TgPAC-Notch3R169C and control mice to confirm and extend these findings. We decided to use the corpus callosum for further analysis, because it contains large bundles of similarly orientated myelin fibers, making it possible to obtain cross-sections of fibers. Two predominant types of lesion were identified unambiguously: (i) membrane-bound vacuoles (Figure 1C-E, pink), which were distinguished from the vascular lumen (Figure 1C-D, yellow or “c”) by the absence of surrounding endothelial cells and astrocytic endfeet, and (ii) whorls of myelin-like figures, probably corresponding to remnants of the myelin sheath (Figure 1E-F, blue and inset). Both lesions were significantly more frequent in mutant than in control mice (Additional file 3: Figure S2, p < 0.05, n = 4 TgPAC-Notch3R169C and 4 control mice). Quantitative morphological analysis showed that vacuoles were the predominant lesions in TgPAC-Notch3R169C mice, accounting for 76.8 ± 5.7% of all lesions, whereas myelin whorls accounted for 14.7 ± 4.2% of all lesions (Figure 1C-G; n = 4 mice). Most vacuoles had a diameter of less than 1 μm (median diameter: 0.83 μm; Figure 1D, white arrows and Figure 1 H), well below the detection threshold of conventional light microscopy at about 3.5 μm, even after correction for eccentric sectioning (expected median vacuole diameter for an observed median diameter of 0.83 μm: 1.13 μm). We found no evidence of fluid accumulation in the interstitial space of TgPAC-Notch3R169C mouse brains. Moreover, elements of the blood–brain barrier, including the endothelial cells with tight junctions, pericytes and astrocytic endfeet, although the latter were occasionally enlarged, were essentially morphologically normal, even when close to vacuoles (Additional file 4: Figure S3). Thus, the brain damage in aged TgPAC-Notch3R169C mice consisted mostly of segmental microvacuolation of the cerebral WM tracts, and electron microscopy was required to assess this damage accurately.
We looked for structural correlates of this microvacuolation by examining high-power electron micrographs of mutant corpus callosum tissue (n = 4 20-month-old TgPAC-Notch3R169C mice). Most vacuoles (83.8 ± 3.0%) were surrounded by myelin, suggesting that they were formed within the myelin sheath (Figure 2A-C). These intra-myelinic vacuoles were generally located in the innermost layers of the myelin sheath (76.5 ± 1.1%), with the axon squashed against one side of the sheath and separated from the vacuole by a thin layer of myelin (Figure 2A, empty arrowhead). These vacuoles generally had a smooth ovoid shape, contained aberrant myelin sheets (Figure 2A, arrows) and were located in the internodal region (Figure 2A-B). They developed less frequently in the outermost layers of the myelin sheath (24 ± 1.1%), where they were surrounded by a thin layer of myelin (Figure 2C, empty arrowheads) and occasionally contained aberrant myelin sheets (Figure 2C, arrows). By contrast, 4.8 ± 1.2% of these vacuoles were located within cells, either in astrocytes (Figure 2D, orange arrows) or in microglial cells. We were unable to determine the precise subcellular location of 11.8 ± 2.6% of vacuoles, these unassigned vacuoles being extremely small (diameter ≤ 0.5 μm; Additional file 5: Figure S4).
We investigated the possibility of a general myelination problem, by determining the g-ratio for apparently intact myelin sheaths. Quantitative analysis of the g-ratio in the corpus callosum revealed no difference between TgPAC-Notch3R169C and control mice (Figure 2G, n = 4 TgPAC-Notch3R169C and 4 control mice, aged 20 months). Overall, these data indicate that segmental intramyelinic oedema, occurring preferentially in the innermost layer of the myelin sheath, can be considered to be the ultrastructural correlate of WM damage in aged TgPAC-Notch3R169C mice.
TgPAC-Notch3R169C mice display progressive focal myelin alteration with poor elimination of myelin debris
We evaluated the integrity of myelin further, by immunolabeling for myelin basic protein (MBP) in TgPAC-Notch3R169C and control mice at 20 months of age. We used the SMI94 monoclonal antibody, which was raised against a peptide of MBP encompassing an epitope known to be unmasked during myelin degradation (Additional file 6: Figure S5) . We found that this antibody, which stains normal myelin, also labeled degraded myelin with a pattern similar to but much more robust than that obtained with the polyclonal antibody commonly used to stain degraded myelin (Additional file 6: Figure S5). The labeling of brain sections with SMI94 resulted in essentially uniform staining of the WM tracts in control mice (n = 8; Figure 3A), whereas it revealed numerous hyperintense foci in the WM tracts, under an almost similar background of staining, in TgPAC-Notch3R169C mice (n = 5; Figure 3B, arrows). Foci were distributed throughout all the WM tracts, including those of the corpus callosum (Figure 3B), fimbria, internal capsule and anterior commissure (data not shown), but were essentially absent from the cortex (Additional file 7: Figure S6). We quantitatively assessed myelin degradation with a quantification algorithm based on the local maxima method, which we applied to the corpus callosum of control and mutant brains labeled with SMI94 (Figure 3C). We found that there was 3.9 times more myelin debris in TgPAC-Notch3R169C mice than in control mice at 20 months of age (Figure 3E, p = 2.6 × 10−5, n = 5 TgPAC-Notch3R169C and 8 control mice). We assessed the progressive nature of myelin degradation in TgPAC-Notch3R169C mice, by analyzing the cerebral WM of younger mice and comparing the results obtained with those for 20-month-old mice. At 12 months of age, TgPAC-Notch3R169C mice had significantly larger amounts of myelin debris than aged-matched control mice (Figure 3D, p = 0.017, n = 4 TgPAC-Notch3R169C and 4 control mice). The amount of myelin debris in TgPAC-Notch3R169C mice was almost four times higher at 20 months than at 12 months, highlighting a large increase in debris load with age. Interestingly, in 12-month-old mice, myelin debris were essentially confined to the anterior periventricular region of the corpus callosum, suggesting that, as in humans, WM lesions begin in the periventricular regions, subsequently expanding towards the cortex in a centripetal manner.
It has recently been shown that the primary loss of oligodendrocytes can lead to myelinic vacuolation [20, 21]. We investigated whether the myelin damage in TgPAC-Notch3R169C mice resulted from oligodendrocyte cell death, by carrying out ultrastructural examinations on mutant mice at 20 months of age. Electron micrographs showed no appreciable ultrastructural abnormalities of the oligodendrocytes in the corpus callosum (data not shown). We then evaluated oligodendrocyte density. Immunolabeling for the oligodendroglial lineage marker Olig2 showed that the density of oligodendrocytes was similar in the cerebral WM of TgPAC-Notch3R169C and control mice (Additional file 8: Figure S7, p >0.05, n = 4 TgPAC-Notch3R169C and 4 control mice). Furthermore, no apoptotic cells were detected on cleaved-caspase 3 immunostaining of the WM tracts of TgPAC-Notch3R169C mice (data not shown).
Microglia plays an essential role in removing tissue debris. There is recent evidence to suggest that the phagocytic clearance of myelin debris is required to prevent a detrimental effect of these debris on the brain and to trigger repair . We began by investigating the microglial response in the cerebral WM of TgPAC-Notch3R169C and control mice at 20 months of age. Immunohistochemistry with an antibody directed against Iba-1, a marker of the total microglial population, resulted in the staining of areas of similar sizes in TgPAC-Notch3R169C and control mice (Figure 4A-B, G; p = 0.99, n = 6 TgPAC-Notch3R169C and 4 control mice). By contrast, immunostaining for CD68, a marker of phagic microglia/macrophages, showed the CD68-positive area in TgPAC-Notch3R169C mice to be slightly, but significantly larger than that in control mice (Figure 4C-D, H; p = 0.037, n = 6 TgPAC-Notch3R169C and 4 control mice). We then assessed the clearance of myelin debris, by counting the number of myelin debris either in contact with or internalized by a microglial cell on brain sections labeled with SMI94 and anti-Iba-1 antibodies. In the corpus callosum, only 13.3 ± 0.7% of the myelin debris was in direct contact with microglial processes or cell bodies (Figure 4E, I; n = 4 TgPAC-Notch3R169C mice). We confirmed this finding through another approach based on electron microscopy. An analysis of electron micrographs of the corpus callosum from TgPAC-Notch3R169C mice revealed that only 6.1 ± 1.8% of abnormal myelin figures were either in contact with or internalized by a migroglial cell (Figure 4F, J, n = 4 TgPAC-Notch3R169C).
Thus, these data indicate that TgPAC-Notch3R169C mice display progressive focal myelin degradation in the cerebral WM that is unlikely to result from oligodendrocyte cell death. They also suggest that this myelin pathology is associated with inefficient phagocytic clearance of the myelin debris.
Myelin pathology in TgPAC-Notch3R169C mice is associated with axon damage
We then hypothesized that axons might be disrupted either as a cause or a consequence of this prominent myelin pathology. Wallerian degeneration is a well-known process in which primary axon degeneration leads to secondary myelin sheath breakdown . Conversely, in multiple sclerosis, for example, axon degeneration is thought to result from demyelination [24, 25]. We studied electron micrographs of the affected areas of WM from 20-month-old TgPAC-Notch3R169C mice (n = 4). Three morphologically different types of lesion were observed: (i) myelin sheath vacuolation with an apparently intact axon generally flattened against one side of the sheath (Figure 5A), (ii) myelin sheath vacuolation with a degenerating axon (Figure 5B) or whorls of myelin-like figures (Figure 1E-F, blue and arrowheads) and (iii) an empty vacuolated myelin sheath with no detectable axon (Figure 5C). Quantitative analysis showed that 49.9 ± 4.4% of damaged myelin sheaths contained an apparently intact axon (lesion type (i)), whereas 49.8 ± 4.3% contained either a degenerating axon or no axon (lesions type (ii) or (iii)) (Figure 5D). We excluded from this quantitative analysis the vacuolated myelin sheaths in which vacuoles formed in the outermost lamellae of the myelin sheath, as it was not possible to determine clearly whether or not the axon was present in these sheaths. We detected no degenerating axons within morphologically normal myelin sheaths.
We also investigated the presence of axons within damaged myelin sheaths on cross-sections of fimbria labeled for phosphorylated light neurofilament and MBP in 20-month-old TgPAC-Notch3R169C mice (n = 5; Figure 5E), to confirm these findings. Color profiling of MBP hyperintense foci on multichannel confocal images led to the identification of three distinct profiles: (i) hyperintense foci with the axon in a central position (Figure 5F), (ii) hyperintense foci with the axon in a lateral position (Figure 5G) and (iii) hyperintense foci with no axon (Figure 5H). Quantitative analysis showed that 54.5 ± 1.4% of foci were associated with an axon profile (lesion types (i) and (ii); Figure 5I). Thus, both ultrastructural and confocal analyses indicate that the myelin pathology in TgPAC-Notch3R169C mice is associated with axonal damage, but that a significant proportion of damaged myelin sheaths still contain an apparently intact axon. This suggests that axonal degeneration occurs secondarily to myelin degradation.
This study provides, to the best of our knowledge, the first detailed microstructural characterization of the initial brain WM lesions in a well-defined form of SVD. Using a mouse model of preclinical CADASIL, we showed that myelin damage was progressive and segmental. It occurred in the absence of oligodendrocyte loss and axonal injury appeared to be secondary. Our findings identify intramyelinic oedema as a prototypic lesion. We also provide evidence for the poor clearance of myelin debris. We found no ultrastructural evidence of blood–brain-barrier leakage, providing further support for the view that prominent changes to the blood–brain barrier are not the mechanism responsible for triggering WM lesions in CADASIL . Our findings shed new light on the potential mechanisms of SVD-related WM changes.
It remains unclear from the results of autopsy studies on patients with SVD whether myelin degradation, axonal injury, oligodendrocyte and neuronal loss are connected or occur sequentially [9, 26, 27]. In this study on a preclinical CADASIL model, we obtained several lines of evidence that myelin injury occurs first, in the absence of oligodendrocyte death. First, oligodendrocytes appeared normal on electron microscopy analysis, with no evidence of abnormal swelling or pyknosis. Second, Olig2 staining showed that there was no change in oligodendrocyte density in the affected WM areas. Finally, immunostaining for cleaved caspase3 revealed an absence of apoptotic oligodendrocytes. Similarly, our data suggest that axonal injury, another pathological change observed in this mouse model of CADASIL, occurs after myelin degradation. We found that about half the altered myelinated sheaths still contained an axon with no overt morphological signs of degeneration. Conversely, none of the morphologically normal myelin sheaths contained a degenerating axon. We also found that the absolute number of injured axons in affected WM areas was small. In particular, staining for non-phosphorylated neurofilaments or an axonal accumulation of APP, which is commonly used to identify and quantify injured axons , revealed no significant differences between mutant and control mice (data not shown). Nevertheless, additional experiments are required for the formal exclusion of more subtle axonal defects, such as changes in axonal transport, which might precede intramyelinic oedema. The lack of prominent axonal degeneration in TgPAC-Notch3R169C mice may account for the lack of an overt clinical phenotype in these mice. This finding may also be of clinical relevance, because it seems likely that NOTCH3 mutation carriers may undergo changes to the WM that remain asymptomatic until a significant number of axons have been injured or other lesions, such as lacunar infarcts, occur.
The identification of segmental intramyelinic oedema as the prototypic lesion sheds new light on the mechanisms of SVD-related WM changes, at least in CADASIL. Intramyelinic oedema is an uncommon phenotype corresponding to the accumulation of ion and water in the periaxonal space or between myelin lamellae. In myelinated axons, repetitive axonal firing leads to continuous movements of ions associated with osmotically driven movements of water. It has been suggested that the so-called “panglial syncytium”, which consists of oligodendrocytes, astrocytes and ependymal cells strongly interlinked by abundant gap junctions, is essential for the long-distance disposal of the excess ions and water released from the periaxonal space (input end) into the pericapillary and subependymal spaces (output end) . This process, which is also known as spatial potassium buffering or siphoning, presumably prevents axonal activation-induced intramyelinic oedema. There is strong evidence, from both mouse models and human diseases, that changes to the molecular components of this panglial syncytium, from the input to the output ends, can ultimately cause ultrastructural lesions of the myelin, with intramyelinic oedema. Mice in which the gap junction coupling of oligodendrocytes and astrocytes is eliminated by the genetic inactivation of both connexins on oligodendrocytes (Cx32 and Cx47) or astrocytes (Cx30 and Cx43) display myelin-associated vacuoles in the cerebral WM tracts, with intramyelinic oedema. This phenotype is greatly attenuated by the suppression of axonal activity, and strongly exacerbated by increases in neuronal activity [29, 30]. In mice, deletion of the gene encoding the potassium channel Kir4.1  or the gene encoding the chloride channel ClC-2 , both of which are strongly expressed in the astrocytic endfeet at the perivascular basal lamina, the output end of the panglial syncytium, leads to WM vacuolation with intramyelinic oedema. Kir4.1 is a weakly rectifying potassium channel, capable of mediating spatial potassium buffering in the central nervous system . There is genetic evidence in mice to suggest that Kir4.1 and connexins are involved in the same pathway [29, 30]. Finally, in humans, a loss of ClC-2 function and dominant mutations of the gene encoding MLC1, a protein that is also highly abundant in the astrocytic endfeet, cause megalencephalic leukoencephalopathy with subcortical cysts, a disease characterized by chronic brain WM oedema in vacuoles predominantly located within myelin sheaths [34, 35]. These findings, together with those presented here, support the notion that early WM lesions in CADASIL may be due to a defect in ion and water homeostasis, providing a new starting point for mechanistic studies.
Mutant NOTCH3 could impair water and ion homeostasis via at least two potential mechanisms. Firstly, chronic hypoperfusion, which has been demonstrated in TgPAC-Notch3R169C mice , may decrease the functioning of ion pumps involved in ionic homeostasis, leading to intramyelinic oedema. Early studies in rodents showed that the cerebral WM was highly vulnerable to ischemia [36, 37]. Remarkably, segmental vacuolation of the WM tracts, with intramyelinic oedema, is one of the most conspicuous and very early pathological changes in ischemic WM induced by brief focal ischemia, in addition to major damage to oligodendrocytes and axons . An energy deficit leads to a decrease in ATP levels, resulting in the failure of several key ATP-dependent ion pumps thought to make a critical contribution to overall ion homeostasis . Alternatively, the mutant NOTCH3 may impair the functioning of astrocytic endfeet, the output end of the panglial syncytium, directly. The astrocytic endfeet cover the abluminal surface of pericytes and smooth muscle cells where mutant NOTCH3 accumulates aberrantly [17, 39]. Further experimental studies are required to test these hypotheses.
We found that myelin degradation was associated with a weak microglial response. Moreover, negligible amounts of myelin debris were eliminated by phagocytosis, as demonstrated by both immunohistochemical and electron microscopy studies, suggesting that the resident microglia was inefficient at the removal of myelin debris. The reasons for this poor clearance of debris remain unclear. Inefficient microglial clearance has been reported to be prevalent in several neurodegenerative diseases and to increase with aging . It has also been suggested that resident microglia clear debris less efficiently in the presence of an intact blood–brain barrier, because of the absence of blood-derived macrophages or stimulation by recruited adaptive immune cells . The clearance of tissue debris is thought to play an important role in creating a proregenerative environment within the central nervous system. The presence of uncleared myelin debris in the central nervous system has been associated with inefficient remyelination and impaired axon regeneration [22, 23].
Our study has several methodological strengths. These include the use of a genetically defined model of SVD in which no surgery was required to obtain the WM phenotype. Bilateral carotid artery stenosis or ligation is commonly used to reproduce mild chronic hypoperfusion and associated ischemic injury to the WM. This model has the disadvantage of requiring a surgical procedure that may itself cause various degrees of transient brain ischemia potentially leading to brain lesions [36, 40]. We assessed the focal degradation of myelin by a quantitative and semi-automatic approach that we developed, which proved to be highly sensitive and robust, with very low interobserver variability (data not shown). This approach has clear advantages over other widely used qualitative or semi-quantitative approaches [19, 41]. Finally, electron microscopy was found to be crucial for the evaluation of vacuolation.
However, this study also has several limitations. We cannot exclude the possibility that WM lesions in CADASIL differ markedly from those in other forms of SVD. However, many studies have highlighted the similarities of WM lesions between patients with CADASIL and those with age- or hypertension-related SVD, particularly as concerns the overall spread of changes across disease stages . We did not attempt to assess cognitive functions in the TgPAC-Notch3R169C mice. A recurrent issue concerning WM changes is their possible association with cognitive deficits, including executive dysfunction in particular, and disability, and the strength of the correlation. However, TgPAC-Notch3R169C mice were generated in the genetic FVB/N background. This background is widely used for genetic manipulations, but behavioral assessments in mice of this strain are complicated due to their relative hyperactivity and severe visual impairment . Finally, it may be of interest to apply novel MRI techniques to TgPAC-Notch3R169C mice, to define neuroradiological correlates of these early WM lesions in CADASIL.
Using TgPAC-Notch3R169C mice as a model of a pure, well defined SVD, we identified intramyelinic oedema as an early and conspicuous feature of cerebral WM changes. Our findings suggest that SVD-related WM changes may be triggered by a defect in ion and water homeostasis. Our results thus provide a new starting point for mechanistic studies of the pathogenesis of SVD–related WM changes.
The data sets supporting the results of this article are included within the article and its additional files.
Bovine serum albumin
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Diffusion Tensor Imaging
Magnetic resonance imaging
Magnetization transfer imaging
Sodium phosphate buffer
Small Vessel Disease
Bejot Y, Catteau A, Caillier M, Rouaud O, Durier J, Marie C, Carlo AD, Osseby G-V, Moreau T, Giroud M: Trends in Incidence, Risk Factors, and Survival in Symptomatic Lacunar Stroke in Dijon, France, From 1989 to 2006 A Population-Based Study. Stroke 2008, 39: 1945–1951. 10.1161/STROKEAHA.107.510933
Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S, American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia: Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 2011, 42: 2672–2713. 10.1161/STR.0b013e3182299496
Pantoni L: Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010, 9: 689–701. 10.1016/S1474-4422(10)70104-6
Wardlaw JM, Smith C, Dichgans M: Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013, 12: 483–497. 10.1016/S1474-4422(13)70060-7
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw F-E, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, van Oostenbrugge R, Pantoni L, Speck O, Stephan BCM, Teipel S, Viswanathan A, Werring D, et al.: Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013, 12: 822–838. 10.1016/S1474-4422(13)70124-8
Patel B, Markus HS: Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int J Stroke 2011, 6: 47–59. 10.1111/j.1747-4949.2010.00552.x
Jones DK, Lythgoe D, Horsfield MA, Simmons A, Williams SCR, Markus HS: Characterization of White Matter Damage in Ischemic Leukoaraiosis with Diffusion Tensor MRI. Stroke 1999, 30: 393–397. 10.1161/01.STR.30.2.393
Fazekas F, Ropele S, Enzinger C, Gorani F, Seewann A, Petrovic K, Schmidt R: MTI of white matter hyperintensities. Brain 2005, 128: 2926–2932. 10.1093/brain/awh567
Schmidt R, Schmidt H, Haybaeck J, Loitfelder M, Weis S, Cavalieri M, Seiler S, Enzinger C, Ropele S, Erkinjuntti T, Pantoni L, Scheltens P, Fazekas F, Jellinger K: Heterogeneity in age-related white matter changes. Acta Neuropathol 2011, 122: 171–185. 10.1007/s00401-011-0851-x
Wen W, Sachdev PS, Chen X, Anstey K: Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample. Neuroimage 2006, 29: 1031–1039. 10.1016/j.neuroimage.2005.08.057
Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, Geurts JJG: Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011, 82: 126–135. 10.1136/jnnp.2009.204685
Yamamoto Y, Craggs L, Baumann M, Kalimo H, Kalaria RN: Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol 2011, 37: 94–113. 10.1111/j.1365-2990.2010.01147.x
Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E: Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996, 383: 707–710. 10.1038/383707a0
Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser M-G: Cadasil. Lancet Neurol 2009, 8: 643–653. 10.1016/S1474-4422(09)70127-9
Joutel A, Faraci FM: Cerebral Small Vessel Disease Insights and Opportunities From Mouse Models of Collagen IV–Related Small Vessel Disease and Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy. Stroke 2014, 45: 1215–1221. 10.1161/STROKEAHA.113.002878
Chabriat H, Levy C, Taillia H, Iba-Zizen MT, Vahedi K, Joutel A, Tournier-Lasserve E, Bousser MG: Patterns of MRI lesions in CADASIL. Neurology 1998, 51: 452–457. 10.1212/WNL.51.2.452
Joutel A, Monet-Leprêtre M, Gosele C, Baron-Menguy C, Hammes A, Schmidt S, Lemaire-Carrette B, Domenga V, Schedl A, Lacombe P, Hubner N: Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J Clin Invest 2010, 120: 433–445. 10.1172/JCI39733
Joutel A: Pathogenesis of CADASIL: transgenic and knock-out mice to probe function and dysfunction of the mutated gene, Notch3, in the cerebrovasculature. Bioessays 2011, 33: 73–80. 10.1002/bies.201000093
Matsuo A, Lee GC, Terai K, Takami K, Hickey WF, McGeer EG, McGeer PL: Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: a potential mechanism for the generation of autoantigens. Am J Pathol 1997, 150: 1253–1266.
Pohl HBF, Porcheri C, Mueggler T, Bachmann LC, Martino G, Riethmacher D, Franklin RJM, Rudin M, Suter U: Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J Neurosci 2011, 31: 1069–1080. 10.1523/JNEUROSCI.5035-10.2011
Traka M, Arasi K, Avila RL, Podojil JR, Christakos A, Miller SD, Soliven B, Popko B: A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain 2010, 133: 3017–3029. 10.1093/brain/awq247
Neumann H, Kotter MR, Franklin RJM: Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132: 288–295.
Vargas ME, Barres BA: Why Is Wallerian Degeneration in the CNS So Slow? Annu Rev Neurosci 2007, 30: 153–179. 10.1146/annurev.neuro.30.051606.094354
Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L: Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338: 278–285. 10.1056/NEJM199801293380502
Trapp BD, Stys PK: Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 2009, 8: 280–291. 10.1016/S1474-4422(09)70043-2
Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser MG: Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke 1993, 24: 122–125. 10.1161/01.STR.24.1.122
Viswanathan A, Gray F, Bousser M-G, Baudrimont M, Chabriat H: Cortical neuronal apoptosis in CADASIL. Stroke 2006, 37: 2690–2695. 10.1161/01.STR.0000245091.28429.6a
Rash JE: Molecular disruptions of the panglial syncytium block potassium siphoning and axonal saltatory conduction: pertinence to neuromyelitis optica and other demyelinating diseases of the central nervous system. Neuroscience 2010, 168: 982–1008. 10.1016/j.neuroscience.2009.10.028
Menichella DM, Majdan M, Awatramani R, Goodenough DA, Sirkowski E, Scherer SS, Paul DL: Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity. J Neurosci 2006, 26: 10984–10991. 10.1523/JNEUROSCI.0304-06.2006
Lutz SE, Zhao Y, Gulinello M, Lee SC, Raine CS, Brosnan CF: Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. J Neurosci 2009, 29: 7743–7752. 10.1523/JNEUROSCI.0341-09.2009
Neusch C, Rozengurt N, Jacobs RE, Lester HA, Kofuji P: Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination. J Neurosci 2001, 21: 5429–5438.
Blanz J, Schweizer M, Auberson M, Maier H, Muenscher A, Hübner CA, Jentsch TJ: Leukoencephalopathy upon disruption of the chloride channel ClC-2. J Neurosci 2007, 27: 6581–6589. 10.1523/JNEUROSCI.0338-07.2007
Olsen ML, Sontheimer H: Functional implications for Kir4.1 channels in glial biology: from K + buffering to cell differentiation. J Neurochem 2008, 107: 589–601. 10.1111/j.1471-4159.2008.05615.x
Van der Knaap MS, Boor I, Estévez R: Megalencephalic leukoencephalopathy with subcortical cysts: chronic white matter oedema due to a defect in brain ion and water homoeostasis. Lancet Neurol 2012, 11: 973–985. 10.1016/S1474-4422(12)70192-8
Depienne C, Bugiani M, Dupuits C, Galanaud D, Touitou V, Postma N, van Berkel C, Polder E, Tollard E, Darios F, Brice A, de Die-Smulders CE, Vles JS, Vanderver A, Uziel G, Yalcinkaya C, Frints SG, Kalscheuer VM, Klooster J, Kamermans M, Abbink TE, Wolf NI, Sedel F, van der Knaap MS: Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study. Lancet Neurol 2013, 12: 659–668. 10.1016/S1474-4422(13)70053-X
Shibata M, Ohtani R, Ihara M, Tomimoto H: White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 2004, 35: 2598–2603. 10.1161/01.STR.0000143725.19053.60
Pantoni L, Garcia JH, Gutierrez JA: Cerebral White Matter Is Highly Vulnerable to Ischemia. Stroke 1996, 27: 1641–1647. 10.1161/01.STR.27.9.1641
Stys PK: Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J Cereb Blood Flow Metab 1998, 18: 2–25.
Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP: The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction. Glia 2010, 58: 1094–1103. 10.1002/glia.20990
Toyama K, Koibuchi N, Uekawa K, Hasegawa Y, Kataoka K, Katayama T, Sueta D, Jie Ma M, Nakagawa T, Yasuda O, Tomimoto H, Ichijo H, Ogawa H, Kim-Mitsuyama S: Apoptosis Signal-Regulating Kinase 1 Is a Novel Target Molecule for Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion. Arterioscler Thromb Vasc Biol 2013, 34: 616–625.
Yamamoto Y, Ihara M, Tham C, Low RWC, Slade JY, Moss T, Oakley AE, Polvikoski T, Kalaria RN: Neuropathological Correlates of Temporal Pole White Matter Hyperintensities in CADASIL. Stroke 2009, 40: 2004–2011. 10.1161/STROKEAHA.108.528299
Duering M, Csanadi E, Gesierich B, Jouvent E, Hervé D, Seiler S, Belaroussi B, Ropele S, Schmidt R, Chabriat H, Dichgans M: Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. Brain 2013, 136: 2717–2726. 10.1093/brain/awt184
Pugh PL, Ahmed SF, Smith MI, Upton N, Hunter AJ: A behavioural characterisation of the FVB/N mouse strain. Behav Brain Res 2004, 155: 283–289. 10.1016/j.bbr.2004.04.021
This work was supported by grants from the French National Research Agency (grant number ANR Genopath 2009-RAE09011HSA and ANR Blanc 2010-RPV11011HHA) and the Fondation Leducq (Transatlantic Network of Excellence on the Pathogenesis of Small Vessel Disease of the Brain) to AJ. EC is a recipient of fellowship from Inserm. We thank Aurélien Dauphin and Andrée Rouche of the Confocal Laser Scanning Microscope Core Facility at “Plate-forme d’Imagerie Cellulaire Pitié Salpêtrière” for providing assistance with confocal microscopy as well Carmen Diaz and Jean Paul Rio of the electron microscopy Core Facility at Institut du Fer-à-Moulin for providing assistance with electron microscopy.
The authors declare that they have no competing interests.
EC and AJ designed the study. EC carried most of the experiments, interpreted the results, wrote the first draft and contributed to the revision of the manuscript. SC participated in the immunohistochemical studies. VD genotyped the mice and participated in the electron microscopy studies. AJ supervised all the experiments, wrote and revised the final draft. All authors read and approved the final manuscript.